Evidence map›Paper›PMID 39789177›Full record

ArticleMikrochimica acta2025

Quantitative determination of leptin hormone using gold nanoparticle-based lateral flow assay.

Erhan Zor, Sabri Alpaydin, Haluk Bingol

Abstract read
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erhan ZorScience and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, Türkiye. zorerhan@gmail.com.
Sabri AlpaydinDepartment of Chemistry Education, A.K. Education Faculty, Necmettin Erbakan University, Konya, Türkiye.
Haluk BingolScience and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, Türkiye.

Funding

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 219Z054
6 · The paper itself

Abstract

A lateral flow assay (LFA) has been developed that can be used in point-of-care (PoC) use for the sensitive determination of leptin hormone. The limit of detection value was 0.158 ng/mL and the limit of quantification value was 0.479 ng/mL for leptin hormone. The stability studies showed that the assay response was equal to the initial value even after 6 months. LFA accuracy tests performed in commercial artificial serum samples were compared with the enzyme-linked immunosorbent assay (ELISA). The obtained recovery values between 95 and 110% show that the developed LFA can be used for quantitative determination of leptin hormone. As the result of the study, a fast and disposable assay was developed for the determination of leptin hormone, which can be performed with a small amount of sample in less than 15 min without the need for long-term analysis stages, qualified personnel, expensive equipment and devices.

Indexed as

LeptinMetal NanoparticlesRheologyAntibodiesHumansHydrogen-Ion ConcentrationAntibodiesLeptinColorimetric lateral flow readerGold nanoparticleLateral flow assayLeptin hormone

Identifiers

PMID39789177
PMCPMC11717784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.